Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | CA12 | O43570 | 4/20 | 0.41 |
| ▸ | CA1 | P00915 | 4/20 | 0.41 |
| ▸ | CA2 | P00918 | 4/20 | 0.41 |
| ▸ | CA9 | Q16790 | 4/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.41 |
| ▸ | CA3 | P07451 | 3/20 | 0.41 |
| ▸ | CA4 | P22748 | 3/20 | 0.41 |
| ▸ | CA7 | P43166 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.41 |
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.41 |
| ▸ | MB | P02144 | 1/20 | 0.41 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.41 |
| ▸ | RARG | P13631 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3279618 | 0.81 | RAB9A (0.53) | ALDH1A1MEN1KMT2ATSHRKDM4E | |
| SCHEMBL874506 | 0.79 | MAPT (0.50) | ALDH1A1MAPTMEN1KMT2AHSD17B1 | |
| SCHEMBL17671272 | 0.79 | MEN1 (0.45) | ALDH1A1MAPTCA1CA2MEN1 | |
| SCHEMBL17671283 | 0.79 | TSHR (0.42) | CA1CA2MEN1KMT2ATSHR | |
| SCHEMBL17671282 | 0.79 | TPMT (0.39) | ALDH1A1MAPTCA1CA2KMT2A | |
| SCHEMBL17671229 | 0.79 | ALOX15 (0.50) | ALDH1A1MAPTCA12CA1CA2 | |
| SCHEMBL7153902 | 0.78 | ESR1 (0.47) | ALDH1A1MAPTCA12CA1CA2 | |
| SCHEMBL440963 | 0.78 | KDM4E (0.48) | ALDH1A1MAPTMEN1CYP3A4KMT2A | |
| SCHEMBL10292556 | 0.78 | ALDH1A1 (0.45) | ALDH1A1MAPTCA12CA1CA2 | |
| SCHEMBL30127710 | 0.78 | ALDH1A1 (0.43) | ALDH1A1MAPTCA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4727818-B2 | — | — | 2011-07-20 | — | — | JP | claimed |
| EP-1128730-B1 | ANTIMICROBIAL COMPOSITION COMPRISING AN OXIDOREDUCTASE AND AN ENHANCING AGENT OF THE N-HYDROXYANILIDE-TYPE | NOVOZYMES AS (DK) | 2003-05-02 | — | — | EP | claimed |
| JP-2002529380-A | — | — | 2002-09-10 | — | — | JP | claimed |
| US-20020094331-A1 | ANTIMICROBIAL COMPOSITION CONTAINING AN OXIDOREDUCTASE AND AN ENHANCER OF THER N-HYDROXYANILIDE-TYPE | NOVOZYMES A/S (DK) | 2002-07-18 | — | — | US | claimed |
| EP-1128730-A1 | ANTIMICROBIAL COMPOSITION COMPRISING AN OXIDOREDUCTASE AND AN ENHANCING AGENT OF THE N-HYDROXYANILIDE-TYPE | Novozymes A/S (DK) | 2001-09-05 | — | — | EP | claimed |
| WO-2000027204-A1 | ANTIMICROBIAL COMPOSITION COMPRISING AN OXIDOREDUCTASE AND AN ENHANCING AGENT OF THE N-HYDROXYANILIDE-TYPE | NOVOZYMES A/S (DK) | 2000-05-18 | — | — | WO | claimed |
| EP-0759171-B1 | PARACETAMOL PHOSPHATE FOR IMMUNOASSAYS | CAMBRIDGE LIFE SCIENCES (GB) | 1998-04-15 | — | — | EP | claimed |
| EP-0759171-A1 | PARACETAMOL PHOSPHATE FOR IMMUNOASSAYS | CAMBRIDGE LIFE SCIENCES PLC (GB) | 1997-02-26 | — | — | EP | claimed |
| WO-1995031724-A1 | PARACETAMOL PHOSPHATE FOR IMMUNOASSAYS | CAMBRIDGE LIFE SCIENCES PLC (GB) | 1995-11-23 | — | — | WO | claimed |
| EP-4585211-A2 | PULLULAN CAPSULES | Capsugel Belgium NV (BE) | 2025-07-16 | — | — | EP | disclosed |
| EP-3609476-B1 | PULLULAN CAPSULES | CAPSUGEL BELGIUM NV (BE) | 2025-06-04 | — | — | EP | disclosed |
| EP-3167869-B1 | TAMPERPROOF ORAL DOSAGE FORM | CAPSUGEL BELGIUM NV (BE) | 2025-02-12 | — | — | EP | disclosed |
| EP-3444336-B1 | CLEANING AGENT | PROCTER & GAMBLE (US) | 2024-05-08 | — | — | EP | disclosed |
| US-11975107-B2 | Compositions and resulting hard capsules comprising hydrophilic coloring foodstuff concentrates | CAPSUGEL BELGIUM NV (BE) | 2024-05-07 | — | — | US | disclosed |
| CN-1041695-A | Medicine for veterinary and human medicine having antiviral and antitumor effects and method for preparing pharmaceutical form comprising the same | BAREND WILLEM HAK (NL) | 1990-05-02 | — | — | CN | disclosed |
| CN-88100516-A | The method of delaying gelatification of water-solubility polymer | — | 1988-09-07 | — | — | CN | disclosed |
| US-4520134-A | ANALGESICS | ROSEN GERALD M (US) | 1985-05-28 | — | — | US | disclosed |
| EP-0116637-A4 | N-ALKYL-4'-HYDROXYACETANILIDES, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND THEIR USE. | ROSEN GERALD M | 1985-02-18 | — | — | EP | disclosed |
| EP-0116637-A1 | N-ALKYL-4'-HYDROXYACETANILIDES, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND THEIR USE | ROSEN, Gerald M. (US) | 1984-08-29 | — | — | EP | disclosed |
| WO-1984000886-A1 | N-ALKYL-4'-HYDROXYACETANILIDES, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND THEIR USE | ROSEN GERALD M | 1984-03-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020094331-A1 | ANTIMICROBIAL COMPOSITION CONTAINING AN OXIDOREDUCTASE AND AN ENHANCER OF THER N-HYDROXYANILIDE-TYPE | LPO, MPO, LCT | ALDH1A1 406/4885MAPT 2768/4885CA12 2336/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.